Tags |
|
|
Links |
|
|
Digg It - Cold Calling's Dark Side
Have you ever wondered why sales managers are so insistent that you cold call?
Have you ever wondered why many companies will n
Have you ever wondered why many companies will n
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ot even consider a marketing budget, and instead mandate cold calling, make it a job requirement, and tell you you’ll be fired i
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
f you don’t do it?
Doesn’t it seem a bit strange that you’d be paid so much in salary just to run around collecting fifty busin
Doesn’t it seem a bit strange that you’d be paid so much in salary just to run around collecting fifty busin
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ess cards a day, or making fifty telephone calls when your talents are so much better than that?
There is a reason for all this
There is a reason for all this
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
insanity. It’s the dark side of cold calling, and the real reasons why many companies still force salespeople to engage in thi
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
s old, antiquated method of doing business.
First of all, cold calling doesn’t cost the company money. It costs you money. Th
First of all, cold calling doesn’t cost the company money. It costs you money. Th
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ey get to avoid spending money on marketing, and instead they let you do the hard work of cold calling. This is in spite of the
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
fact that cold calling has the lowest returns of any and all sales activities, and therefore leaves you with the lowest possible
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
paycheck.
Second, cold calling doesn’t cost the company time. If they wanted to put together a marketing plan they’d either h
Second, cold calling doesn’t cost the company time. If they wanted to put together a marketing plan they’d either h
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ave to hire more employees to do it, take current employees away from other duties, or hire an outside firm to implement it. In
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
stead, they tell you to do it. This saves manpower and eliminates the need to either hire new employees or hire an outside cons
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ultant. The end result is that is costs you time and forces you to waste your valuable time on the lowest-percentage sales acti
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
vity instead of on something more productive.
The insanity of all this is that trying to save time and money by forcing you to
The insanity of all this is that trying to save time and money by forcing you to
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
cold call ends up costing the company huge amounts of time and money! It obviously isn’t profitable to have salespeople cold ca
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ling when it consistently has the lowest returns of all sales activities. However, they do it anyway, with the belief that it’s
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
a smart way to cut corners. The fact of the matter is that having salespeople cold call is penny-wise and pound-foolish. It l
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ets companies cut corners in the short term, but with very dire long-term consequences. Cold calling, when relied upon as the m
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ain source of new business, frequently leads to lost profits, downsizing and even bankruptcy.
Companies that are succeeding tod
Companies that are succeeding tod
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ay don’t bother with cold calling. They implement a marketing plan that generates qualified leads, and they provide those leads
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
to the salespeople, who simply go out and close them. This is the only sensible way to do business in the twenty-first century
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/39076/diggit-Cold-Callings-Dark-Side.html">Cold Calling's Dark Side</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/39076/diggit-Cold-Callings-Dark-Side.html]Cold Calling's Dark Side[/url]
Related Articles:
The Newest Commodity In Big Business - Carbon Credits
What is an Artist's Statement & How Often Should It Be Updated?
Bite Your Tongue; They Might Think You are Arrogant
Bookmark it:
|